By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australian genetic test company Genetic Technologies said on Monday that it posted A$1.5 million (US$1.6 million) in revenues for its fiscal second quarter.

The company had no reported R&D spending during the quarter ended Dec. 31, 2011. Advertising and marketing expenses came in at A$92,651.

Genetic Technologies said it had a net loss of A$2.2 million and ended the quarter with A$12.6 million in cash.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.